Elevation of serum creatine kinase during methimazole treatment of Graves disease in a 13-year-old girl and a literature review of similar cases
Hyeseon Kim, Jinsup Kim, Rimm Huh, Sung Yoon Cho, Dong-Kyu Jin
Ann Pediatr Endocrinol Metab. 2015;20(2):106-109.   Published online 2015 Jun 30     DOI: https://doi.org/10.6065/apem.2015.20.2.106
Citations to this article as recorded by Crossref logo
Myopathy Associated with Treatment of Graves’ Disease
Yoon-Kyung Ji, Shin-Hee Kim
Medicina.2021; 57(10): 1016.     CrossRef
Thionamide-Induced Myositis
Koshy Nithin Thomas, Sujata Ganguly, Durga Prasanna Misra, Ramnath Misra, Latika Gupta
JCR: Journal of Clinical Rheumatology.2021; 27(8S): S437.     CrossRef
Myopathy after rapid correction of hyperthyroidism
Ran Lu, Haining Wang, Tianpei Hong, Hongwei Gao
Medicine.2020; 99(3): e18878.     CrossRef
Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs
Ying Cheng, Zhiyong Sun, Dapeng Zhong, Li Ren, Hang Yang
Medicine.2020; 99(43): e22898.     CrossRef
Erratic movement disorders disclosing Graves’ disease and paralleling thyroid function but not autoantibody levels
Sébastien Delhasse, Ines Debove, Gabriella Arnold-Kunz, Joseph-André Ghika, Joelle Nsimire Chabwine
Journal of International Medical Research.2019; 47(3): 1378.     CrossRef
Myopathy in hyperthyroidism as a consequence of rapid reduction of thyroid hormone
Qianrui Li, Yuping Liu, Qianying Zhang, Haoming Tian, Jianwei Li, Sheyu Li
Medicine.2017; 96(30): e7591.     CrossRef
Reactions Weekly.2015; 1564(1): 201.     CrossRef